Abstract
We describe two Li-Fraumeni syndrome families. Family A was remarkable for two early childhood cases of adrenocortical tumours, family B for a high incidence of many characteristic cancers, including a childhood case of choroid plexus tumour. Using direct sequencing, we analysed exons 5-9 of the p53 gene in constitutional DNA of individuals from both families and found two novel germline mutations in exon 5. In family A, we detected a point substitution in codon 138 (GCC to CCC), which resulted in the replacement of the alanine by a proline residue. Family B harboured a single-base pair deletion in codon 178 (CAC to -AC), resulting in a frameshift and premature chain termination. Three out of six tumours examined from both families, a renal cell carcinoma, a rhabdomyosarcoma and a breast cancer, showed loss of heterozygosity and contained only the mutant p53 allele. The remaining three neoplasms, both adrenocortical tumours and the choroid plexus tumour retained heterozygosity. Immunohistochemistry with anti-p53 antibody confirmed accumulation of p53 protein in tumours with loss of heterozygosity, while the remaining tumours were p53 negative. These results support the view that complete loss of activity of the wild-type p53 need not be the initial event in the formation of all tumours in Li-Fraumeni individuals.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sedlacek, Z., Kodet, R., Kriz, V. et al. Two Li-Fraumeni syndrome families with novel germline p53 mutations: loss of the wild-type p53 allele in only 50% of tumours. Br J Cancer 77, 1034–1039 (1998). https://doi.org/10.1038/bjc.1998.172
Issue Date:
DOI: https://doi.org/10.1038/bjc.1998.172
This article is cited by
-
Jdp2 downregulates Trp53 transcription to promote leukaemogenesis in the context of Trp53 heterozygosity
Oncogene (2013)
-
Late-Onset Common Cancers in a Kindred with an Arg213Gln TP53 Germline Mutation
Familial Cancer (2006)
-
TP53 Gene Mutations Are Rare in Nondysplastic Barrett's Esophagus
Digestive Diseases and Sciences (2006)
-
Investigations on a clinically and functionally unusual and novel germline p53 mutation
British Journal of Cancer (2002)
-
Tissue-specific expression of SV40 in tumors associated with the Li–Fraumeni syndrome
Oncogene (2001)